Estrogens have long been thought to be important in the etiology of endometrial cancer, but in subjects of advanced postmenopausal age the ovary no longer produces estrogens. Calanog (3) reported that the level of androstenedione and the rate of its conversion to estrone were higher in patients with endometrial cancer than in control postmenopausal subjects. Moreover, testosterone secretion from the ovary is also significantly increased in patients with endometrial cancer (2, 4) . On the other hand, Judd (8, 9) reported that the levels of androstenedione, testosterone, estrone and estradiol in patients with endometrial cancer were similar to those in control postmenopausal subjects, and MacDonald (12) observed that obesity enhanced the conversion of androstenedione to estrone in postmenopausal women with or without endometrial cancer.
Thymidine kinase (TK; EC 2.7.1.21), which acts in the pyrimidine salvage pathway, catalyzes the phosphorylation of deoxythymidine and is involved in DNA replication. High TK activity has been found in proliferating tissues (6, 13, 14, 19) . We previously found that progesterone inhibited uterine TK activity induced by estrogen in immature rats (16) , but the effects of androgens on the endometrium or their role in endometrial cancer are still unclear. Therefore, in the present work, we examined the effects of androgen on TK activity and its isozymes and on [3H]-thymidine incorporation into rat uteri. Scirpa (18) found that the plasma androstenedione levels in patients with endometrial hyperplasia were significantly higher than those of normal pre-or post-menopausal subjects, whereas their plasma estrone levels were similar to those of the normal subjects. On the other hand, Kaslaris and Jull (10) observed that the induction of uterine tumors in mice by chemical carcinogens was suppressed by androgen administration. This may have been because androgen probably reduces ovarian secretion of estrogen by a pituitary feedback mechanism in mature mice with a normal estrous cycle. In women after menopause, ovarian secretion of androgen in place of estrogen increases (8) with the increase in the rate of conversion of androstenedione to estrone (3) .
Androgen is known to stimulate uterine cell proliferation (7, 11) , and it has a specific receptor in the rat uterus (15) , though a large dose of androgen can bind to the estrogen receptor in the uterus (17) , and androgen may be converted to estrogen in vitro (3). However, there are reports that testosterone and 5a-dihydrotestosterone have strong affinities for the uterine androgen receptor (15) , and that testosterone does not bind to the estrogen receptor in vivo (17, 20) . These reports suggest that the effect of testosterone on uterine TK activity is not related to the estrogen receptor, and that estrogen and androgen increase uterine TK activity independently. We found that estrogen and androgen both stimulated the endometrial stroma and myometrium, and that they had more effect in combination than singly on the activities of crude TK and the partially purified TK isozymes (Tables 1 and 2 ), and on [3H]-thymidine incorporation into immature rat uteri ( Fig. 2 and 
